Accessibility Menu
Equillium logo

Equillium

(NASDAQ) EQ

Current Price$3.09
Market Cap$194.74M
Since IPO (2018)-78%
5 Year-48%
1 Year+894%
1 Month+6%

Equillium Financials at a Glance

Market Cap

$194.74M

Revenue (TTM)

$0.00

Net Income (TTM)

-$19.06M

EPS (TTM)

-$0.32

P/E Ratio

-9.57

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Price

$3.09

Volume

3,245

Open

$3.05

Previous Close

$3.08

Daily Range

$2.98 - $3.12

52-Week Range

$0.29 - $3.45

Estimated Earnings Date

Aug 13, 2026

EQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Equillium

Industry

Biotechnology

Employees

14

CEO

Bruce D. Steel, CFA, MBA

Headquarters

La Jolla, CA 92037, US

EQ Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-61.43%

Return on Capital

-80.62%

Return on Assets

-30.21%

Earnings Yield

-10.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$194.74M

Shares Outstanding

63.23M

Volume

3.25K

Avg. Volume

602.64K

Financials (TTM)

Gross Profit

-$79.00K

Operating Income

-$20.38M

EBITDA

-$18.95M

Operating Cash Flow

-$18.88M

Capital Expenditure

-$47.00K

Free Cash Flow

-$18.93M

Cash & ST Invst.

$61.32M

Total Debt

$692.00K

Equillium Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$24.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$194.74M

N/A

Market Cap/Employee

$5.56M

N/A

Employees

35

N/A

Net Income

-$5.31M

+38.6%

EBITDA

-$5.29M

+38.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$61.32M

+322.9%

Total Debt

$692.00K

+134.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$251.00K

+68.5%

Short Term Debt

$441.00K

+202.1%

Return on Assets

-30.21%

N/A

Return on Invested Capital

-34.11%

N/A

Free Cash Flow

-$4.30M

+47.3%

Operating Cash Flow

-$4.30M

+47.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPSCCentury Therapeutics, Inc.
$2.41+3.88%
FBIOFortress Biotech, Inc.
$2.95+6.88%
CUECue Biopharma, Inc.
$30.43+19.85%
SPRBSpruce Biosciences, Inc.
$55.88+1.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.03+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.19+0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.64+0.17%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.16-0.08%

Questions About EQ

What is the current price of Equillium?

Equillium is trading at $3.08 per share.

What is the 52-week range for Equillium?

Over the past 52 weeks, Equillium has traded between $0.29 and $3.45.

How much debt does Equillium have?

As of the most recent reporting period, Equillium reported total debt of $692.00K.

How much cash does Equillium have on hand?

Equillium reported $61.32M in cash and cash equivalents in its most recent financial results.

What is Equillium’s dividend yield?

Equillium does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.